Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 4Lymphoma, Follicular 3Neoplasms 2Prostatic Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasms, Nerve Tissue 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 95Peripheral Blood Stem Cell Transplantation 82Filgrastim 60fludarabine phosphate 55Etoposide 54Radiotherapy 45Rituximab 44Mycophenolic Acid 42Cyclosporine 39Busulfan 39Whole-Body Irradiation 35Melphalan 35Tacrolimus 32Antilymphocyte Serum 31Cytarabine 27Methotrexate 26Carmustine 23Methylprednisolone 22Cord Blood Stem Cell Transplantation 17sargramostim 16Vincristine 15Prednisone 15Granulocyte Colony-Stimulating Factor 14Flow Cytometry 13Doxorubicin 13Therapeutics 12Carboplatin 11Thiotepa 10Polymerase Chain Reaction 10Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Large-Cell, Immunoblastic × keyhole-limpet hemocyanin × Clear all
NCT00004197 2023-09-07

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

University of Nebraska

Phase 2 Completed
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡